文献速递乳腺USMR

超声造影(CEUS)在伴钙化乳腺病灶诊断中是否优于MRI?一项对比研究

Does contrast-enhanced ultrasound (CEUS) play a better role in diagnosis of breast lesions with calcification? A comparison with MRI.
PubMed 文献 · Br J Radiol · 2020-06-02

研究纳入51例患者的52个伴钙化乳腺病灶,比较超声BI-RADS、MRI-BI-RADS与CEUS-BI-RADS的诊断效能。CEUS-BI-RADS特异度96.8%、准确率96.1%,高于MRI-BI-RADS的78.1%和82.6%(p<0.05);三者敏感度及AUROC无显著差异(p>0.05)。结论认为CEUS-BI-RADS对伴钙化乳腺病灶的鉴别诊断效能优于MRI-BI-RADS。

要点

  • 伴钙化乳腺病灶中,CEUS-BI-RADS特异度96.8%、准确率96.1%,均高于MRI-BI-RADS的78.1%和82.6%(p<0.05)。
  • 超声BI-RADS、MRI-BI-RADS与CEUS-BI-RADS敏感度分别为85%、90%、95%,三者无显著差异(p>0.05)。
  • CEUS-BI-RADS的AUROC为0.945,MRI-BI-RADS为0.907,超声BI-RADS为0.853,三者无显著差异(p>0.05)。

核心结论

  • CEUS-BI-RADS对伴钙化乳腺病灶的鉴别诊断效能优于MRI-BI-RADS。

研究设计与样本

  • 研究纳入51例患者的52个伴钙化乳腺病灶,超声检出为高回声灶并分类为BI-RADS 3-5类。
  • 51例患者进一步接受CEUS检查和MRI检查,以组织病理学为金标准。
  • 超声BI-RADS联合CEUS 5点评分系统重新定义BI-RADS分类,称为CEUS-BI-RADS。
  • 采用受试者工作特征(ROC)曲线分析评估三种方法的诊断效能。

诊断标准与关键数值

  • 超声BI-RADS、MRI-BI-RADS与CEUS-BI-RADS的敏感度分别为85%、90%、95%,三者无显著差异(p>0.05)。
  • 超声BI-RADS、MRI-BI-RADS与CEUS-BI-RADS的特异度分别为78.1%、78.1%、96.8%(p<0.05)。
  • 超声BI-RADS、MRI-BI-RADS与CEUS-BI-RADS的准确率分别为80.7%、82.6%、96.1%(p<0.05)。
  • CEUS-BI-RADS、MRI-BI-RADS与超声BI-RADS鉴别伴钙化乳腺病灶的AUROC分别为0.945、0.907、0.853,三者无显著差异(p>0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the efficacy of contrast-enhanced ultrasound enabled reclassification of Breast Imaging Reporting and Data System (CEUS-BI-RADS) with MRI in the diagnosis of breast lesions with calcification.

METHODS: A total of 52 breast lesions with calcification from 51 patients were detected by ultrasound as hyperechoic foci and categorized as BI-RADS 3-5. The 51 patients further underwent CEUS scan and MRI. The ultrasound-BI-RADS combined with CEUS 5-point score system redefined the classification of BI-RADS which was called CEUS-BI-RADS. The diagnostic efficacy of three methods was assessed by receiver operating characteristic (ROC) curve analysis. Histopathological assessment used as the gold-standard.

RESULTS: The sensitivities of Ultrasound-BI-RADS, MRI classification of BI-RADS (MRI-BI-RADS) and CEUS-BI-RADS were 85%, 90% and 95% without significant difference among the three modalities (p > 0.05). The diagnostic specificities of ultrasound-BI-RADS, MRI-BI-RADS and CEUS-BI-RADS were 78.1%, 78.1% and 96.8%, respectively (p < 0.05); and the accuracy were 80.7%, 82.6% and 96.1% for ultrasound-BI-RADS, MRI-BI-RADS and CEUS-BI-RADS, respectively (p < 0.05). The area under ROC (AUROC) in differentiation of breast lesions with calcification was 0.945 for CEUS-BI-RADS, 0.907 for MRI-BI-RADS and 0.853 for ultrasound-BI-RADS, with no significant difference among the three modalities (p > 0.05).

CONCLUSION: The CEUS-BI-RADS has a better diagnostic efficiency than MRI-BI-RADS in the differentiation of the breast lesions with calcification.

ADVANCES IN KNOWLEDGE: •CEUS is a better method in differentiation of breast lesions with calcification.•CEUS-BI-RADS increases the efficiency of diagnosis compared to MRI.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Pan J, Tong W, Luo J, et al. Does contrast-enhanced ultrasound (CEUS) play a better role in diagnosis of breast lesions with calcification? A comparison with MRI. Br J Radiol. 2020. PMID: 32463295. doi:10.1259/bjr.20200195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。